Analysis of polypeptide expression in benign and malignant human breast lesions; down-regulation of cytokeratins

British Journal of Cancer

Volumn 74, Issue 10, 1996, Pages 1632-1638

  Franzen B ^a   Linder, S ^a   Alaiya, A A ^a   Eriksson, E ^a   Uruy, K ^b   Hirano, T ^b   Okuzawa, K ^b   Auer, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokeratin; Human breast tumour; Two dimensional gel electrophoresis

Indexed keywords

CALRETICULIN; CYCLINE; CYTOKERATIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90; LACTATE DEHYDROGENASE; TROPOMYOSIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROADENOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0029903843     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.600     Document Type: Article

References (26)

1. ANDERSON NL. (1992). Two Dimensional Electrophoresis, Operation of the ISO-DALT System. Large Scale Biology Press: Washington DC.
2. AUER GU, CASPERSSON T AND WALLGREN A. (1980). DNA content and survival in mammary carcinoma. Anal. Quant. Cytol. Histol., 3, 161-165.
3. CELIS JE, HOLM RASMUSSEN H, GROMOV P, OLSEN E, MADSEN P, LEFFERS H, HONORE B, DEJGAARD K, VORUM H, BACK KRISTENSEN D, ØSTERGARD M, HANSØ A, AAGARD JENSEN N, CELIS A, BASSE B, LAURIDSEN JB, RATZ GP, ANDERSEN AH, WALBUM E, KJAERGAARD I, ANDERSEN I, PUYPE M, VAN DAMME J AND VANDERKERCKHOVE J. (1995). The human keratinocyte two-dimensional gel protein database (update 1995): mapping components of signal transduction pathways. Electrophoresis, 16, 2177-2240.
4. DANIEL V. (1993). Glutathione S-transferases: gene structure and regulation of expression. Crit. Rev. Biochem. Mol. Biol., 28: 173-207.
5. FRANZÉN B, OKUZAWA K, LINDER S, KATO H AND AUER G. (1993). Non-enzymatic extraction of cells from clinical tumour material for analysis of gene expression by two-dimensional gel electrophoresis. Electrophoresis, 14, 382-390.
6. FRANZÉN B, LINDER S, URYU K, ALAIYA AA, HIRANO T, KATO K AND AUER G. (1996). Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br. J. Cancer, 73, 909-913.
7. GARRELS JI. (1979). Two-dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines. J. Biol. Chem., 254, 7961-7977.
8. GARRELS JI, FARRAR JT AND BURWELL CB. (1984). The QUEST system for computer-analyzed two-dimensional gel electrophoresis of proteins. In Two-Dimensional Gel Electrophoresis of Proteins: Methods and Applications, Celis JE and Bravo R. (eds) pp. 37-91. Academic Press: New York.
9. GARRELS JL AND FRANZA BJ. (1989). Transformation-sensitive and growth-related changes of protein synthesis in REF52 cells. A two-dimensional gel analysis of SV40-, adenovirus-, and Kirsten murine sarcoma virus-transformed rat cells using the REF52 protein database. J. Biol. Chem., 264, 5299-5312.
10. HARBECK N, UNTCH M, PACHE L AND EIERMANN W. (1994). Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br. J. Cancer, 69, 566-571.
11. HEATLEY M, MAXWELL P, WHITESIDE C AND TONER P. (1995). Cytokeratin intermediate filament expression in benign and malignant breast disease. J. Clin. Pathol., 48, 26-32.
12. JOOSS KU AND MULLER R. (1995). Deregulation of genes encoding microfilament-associated proteins during Fos-induced morphological transformation. Oncogene, 10, 603-608.
13. LEBEAU J, LE CHALONY C, PROSPERI MT AND GOUBIN G. (1991). Constitutive overexpression of a 89kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene. Oncogene, 6, 1125-1132.
14. LINDER S, BRESKI H AND RINGERTZ NR. (1979). Phenotypic expression in cybrids derived from teratocarcinoma cells fused with myoblast cytoplasms. Exp. Cell Res., 120, 1-14.
15. MATSUMURA F AND YAMASHIRO-MATSUMURA S. (1985). Purification and characterization of multiple isoforms of tropomyosin from rat cultured cells. J Biol. Chem., 260, 13851-13859.
16. MOLL R. (1992). Molecular diversity of cytokeratins: significance for cell and tumor differentiation. Ada Histochem., 41 (Suppl.), 117-127.
17. OKUZAWA K, FRANZÉN B, LINDHOLM J, LINDER S, HIRANO T, BERGMAN T, EBIHARA Y, KATO H AND AUER G. (1994). Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis, 15, 382-390.
18. PAINE TM, FONTANINI G, BASOLO F, GERONIMO I, ELLIOTT JW AND RUSSO J. (1992). Mutated c-Ha-ras oncogene alters cytokeratin expression in the human breast epithelial cell line MCF-10A. Am. J. Pathol., 140, 1483-1488.
19. PANTEL K, SCHLIMOK G, BRAUN S, KUTTER D, LINDEMANN F, SCHALLER G, FUNKE I, IZBICKI JR AND RIETHMULLER G. (1993). Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl Cancer Inst., 85, 1419-1424.
20. PAULIN D, FOREST N AND PERREAU J. (1980). Cytoskeletal proteins used as marker of differentiation in mouse teratocarcinoma cells. J. Mol. Biol., 144, 95-101.
21. RAMAEKERS FC, BECK H, VOOIJS GP AND HERMAN CJ. (1984). Flow-cytometric analysis of mixed cell populations using intermediate filament antibodies. Exp. Cell Res., 153, 249-253.
22. STEEG PS, DE LA ROSA A, FLATOW U, MACDONALD NJ, BENEDICT M AND LEONE A. (1993). Nm23 and breast cancer metastasis (Review). Breast Cancer Res. Treat., 25, 175-187.
23. TAKEI H, IINO Y, HORIGUCHI J, KANOH T, TAKAO Y, OYAMA T AND MORISHITA Y. (1995). Immunohistochemical analysis of cytokeratin 8 as a prognostic factor in invasive breast carcinoma. Anticancer Res., 15, 1101-1105.
24. TRASK DK, BAND V, ZAJCHOWSKI DA, YASWEN P, SUH T AND SAGER R. (1990). Keratins as markers that distinguish normal and tumor-derived mammary epithelial cells. Proc. Natl Acad. Sci. USA, 87, 2319-2323.
25. WADA T, YASUTOMI M, YAMADA K, HASHIMURA K, KUNIKATA M, TANAKA T, HUANG JW AND MORI M. (1991). Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases. Anticancer Res., 11, 1983-1993.
26. WINGREN SOS AND NORDENSKJÖLD B. (1994). Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. South East Swede Breast Cancer Group. Br. J. Cancer, 69, 546-549.